Total Visits

Views
IMscin001 ...34

Total Visits Per Month

September 2023October 2023November 2023December 2023January 2024February 2024March 2024
IMscin001 ...2900800

File Visits

Views
imscin001_part_2_a_randomised_phase_iii_open_label_multicentre_study_examining_pharmacokinetics_efficacy_immunogenicity_safety_atezolizumab_subcutaneous_2023.pdf13

Top country views

Views
United States23
France3
South Korea3
China2
Germany2
Spain1

Top cities views

Views
Boydton4
Paris3
Beijing2
Barcelona1
Boardman1
Chicago1
Rietheim-Weilheim1